Log In
BCIQ
Print this Print this
 

CP-870,893

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
Description mAb targeting CD40
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerVLST Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/03/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today